U.S. pharma large copyright scrapped two experimental weight loss pills previous yr—a the moment-daily tablet, lotiglipron, on account of elevated liver enzymes as well as a two times-each day pill, danuglipron, as a consequence of potent Uncomfortable side effects—but CEO Albert Bou